Abstract Retinitis pigmentosa (RP) is a clinically and genetically heterogeneous form of retinal degeneration. Several genes and loci have been shown to be involved in the disease, although each of them only accounts for a few cases. Mutations in the gene encoding ROM1, a rod-specific protein, have been putatively associated with several forms of RP. Here we describe a double-mutant allele of this gene, P60T and T108M, present in two affected sibs and also in two healthy members of a Spanish RP family. The same double-mutant allele was previously considered to be responsible for autosomal dominant RP in one family. We now report data that question the potential pathogenicity of these two ROM1 mutations.
Introduction
Retinitis pigmentosa (RP) is a group of inherited retinal disorders characterized by a progressive constriction of peripheral visual fields, night blindness, and, eventually, severe visual impairment (Heckenlively et al. 1988 ). Both linkage analysis and the candidate gene approach have identified several RP genes and loci (Dryja and Li 1995) , but the genetic defect in most cases remains unknown.
One such gene is that encoding the rod outer segment membrane protein (ROM1) (Kajiwara et al. 1994; Bascom et al. 1995; Sakuma et al. 1995) . Its product was first identified as a disk-rim protein, present in the rod outer segment and absent in cones (Bascom et al. 1992) . However, recent experiments with anti-ROM1 antibodies suggest that it could be present in both types of photoreceptor cells (Moritz and Molday 1996) .
To identify the molecular defect underlying the disease in an RP family, eight candidate genes were analyzed. The two affected sibs bore a double-mutant allele of ROM1, P60T and T108M. This allele has been described as the cause of RP in another family (Bascom et al. 1995) .
Materials and methods

Pedigree and clinical evaluation
The pedigree studied (referred to as V-8) comprises two branches with a total of three affected members (Fig. 1) . Clinical and electrophysiological studies (Table 1) included measurement of visual acuity, fundus examination, visual field testing, electroretinogram (ERG), electrooculogram (EOG) and dark adaptation. Ganzfeld ERGs were assessed, for both affected and nonaffected members of the family, according to the International Society for the Clinical Electrophysiology of Vision Standards (ISCEV). Rod-isolated responses were obtained under scotopic dark-adapted (20 min) conditions, mixed cone-rod responses with single flashes of white light in scotopic conditions and cone-isolated responses with 30 Hz white flickering light in fotopic conditions. EOG testing was performed following the ISCEV protocol using a Ganzfeld stimulator and a Compact Four Ca-2000 computer (Nicolet).
Informed consent was obtained from all subjects after the nature and possible consequences of the study had been explained.
Analysis of DNA polymorphisms
Genomic DNA was extracted from peripheral blood according to Miller et al. (1988) phosphodiesterase (PDEB), rhodopsin (RHO) and recoverin (D17S786) genes were from the MapPairs set (Research Genetics, Huntsville, AL). The polymorphisms of the peripherin/RDS gene were as described elsewhere (Kumar-Singh et al. 1991; Bayés et al. 1996) . Two internal variants, 1447A/G and 1683delC, were used for cosegregation analyses of the γ-subunit of rod phosphodiesterase (PDEG) (Hahn et al. 1994) . Finally, cosegregation with S antigen (SAG) was studied using an intragenic triallelic polymorphism (Sheffield et al. 1992) , detected by allele-specific oligonucleotide hybridization.
Polymerase chain reaction (PCR) conditions were as follows: genomic DNA (300 ng) was amplified in a 25-µl reaction mixture containing 6.6 pmol of each primer, 1 U of Dynazyme DNA polymerase (Fynzymes Oy, Espoo, Finland) in the recommended buffer and 200 µM dNTPs. The PCR amplification profile was: 94°C, 40 s; 50°-60°C, 30 s (× 35); 72°C, 5 min (× 1).
Mutation analysis
A PCR-SSCP (single-strand conformation polymorphism) strategy was used for mutation screening. Oligonucleotide primers flanking the coding regions of the PDEG, peripherin/RDS and ROM1 genes were designed according to the published genomic sequences (Travis et al. 1991; Bascom et al. 1993a; Piriev et al. 1994) . For the neural retinal leucine zipper (NRL) gene, primers were kindly provided by Dr. A. Swaroop. Oligonucleotides to amplify the coding regions of PDEB and RHO were as described elsewhere (Keen et al. 1991; Riess et al. 1992) . PCR conditions were as described above except for a final reaction volume of 50 µl. The protocol for SSCP analysis has been published elsewhere (Bayés et al. 1995) . All samples were run under three sets of conditions, with varying acrylamide and glycerol concentrations and running temperatures. DNA sequencing PCR products giving an aberrant SSCP pattern were purified by the QIAquick-spin PCR Purification Kit (Qiagen, Chatsworth, USA) and cloned into pUC18 using the Sure Clone Ligation Kit (Pharmacia Biotech, Uppsala, Sweden). Three to five mutant clones were sequenced in each case by the dideoxy chain-termination method using the T7 Sequencing Kit (Pharmacia). When the variant identified altered the recognition site for a restriction enzyme, PCR products were further digested with the corresponding enzyme to confirm the nucleotide change.
Results and discussion
The pattern of inheritance of RP in family V-8 (Fig. 1) is unclear. Individuals I.1 and I.2 are descendants from a consanguineous marriage and members I.2 and I.3 come from the same small village. These data suggest a recessive pattern of inheritance. However, the presence of affected individuals in two generations (three females), would favor the hypothesis of RP segregating as a dominant trait. If this is the case, incomplete penetrance would have to be assumed. Heterogeneity in phenotypic expression due to incomplete penetrance has already been documented in autosomal dominant RP (ADRP) families (Berson and Simonoff 1979; Kim et al. 1994) .
Clinical and electrophysiological data of the available affected and healthy members are shown in Table 1 . The probands, individuals II.4 and II.5, present a typical form of RP. According to clinical records, individual I.1 had also been diagnosed as affected with RP. Individual I.2, the mother of the probands, showed decreased visual acuity values and ERGs, which could be attributable to both cataracts and age, while her fundus examination appeared totally normal. The clinical parameters of the remaining members examined were all within the normal ranges, although there was a high degree of variability for the ERG values. Individuals III.1, III.3 and III.4 were healthy at the time of the study but, considering the age of onset of RP in their mothers, they were still too young to be diagnosed with certainty. Finally, individuals II.1, II.2 and II.3 denied having any visual impairment. The involvement in the disease of the PDEB, PDEG, peripherin/RDS, recoverin, RHO, NRL, SAG and ROM1 genes was assessed by combining cosegregation and mutation analyses. Four aberrant SSCP patterns were detected, corresponding to PCR fragments of exon 22 of PDEB, exon 3 of NRL and exons 1 and 2 of ROM1. Cloning and sequencing of the PDEB fragment revealed a known polymorphism, 2598G/A . Moreover, analysis of exon 3 of NRL identified a novel silent nucleotide substitution, 4723C/T.
The third aberrant SSCP pattern revealed a ROM1 allele with two nucleotide changes, each leading to an amino acid substitution, P60T and T108M. This doublemutant allele is identical to that described by Bascom et al. (1995) in only the affected members of a small ADRP family. However, in V-8 the ROM1 allele is present in all the affected individuals as well as in some healthy members (Fig. 1) . To exclude minimal functional disturbances in some of these subjectively healthy carriers, individuals I.2, II.3 and II.6 were subjected to EOG and dark adaptation tests. Individual I.2 (aged 72) showed an EOG Arden ratio of 150 (normal values are above 180; see Table 1) , and the rod threshold of the dark adaptation curve was slightly increased. However, these results could be attributable, again, to both cataracts and age. Individuals II.3 and II.6 showed EOG ratios of 200 and their dark adaptation curves were normal.
Finally, analysis of the fourth aberrant SSCP pattern, corresponding to exon 2 of ROM1, identified the 1071G/C polymorphism (Bascom et al. 1993b ) and a segregation study showed that the two affected sisters had inherited different paternal alleles (Fig. 1) . Taking these data together, the involvement of the ROM1 gene in a recessive form of the disease is ruled out in this family. Kajiwara et al. (1994) reported a digenic form of RP in three families due to mutations in the ROM1 and RDS genes. To test this model, we analyzed the peripherin/RDS internal polymorphisms 558C/T and 1294C/T in our family; the results showed that the affected sibs did not share the paternal peripherin/RDS allele. Thus, the hypothesis of a digenic ROM1/RDS pattern of inheritance is ruled out.
The role of the ROM1 double-mutant allele in RP is still unclear. Nevertheless, in family V-8 there is a correlation between its presence and abnormal or low ERG values. Unaffected individuals bearing this allele showed the lowest ERG recordings (see Table 1 ). Additionally, the mutant allele has only been described in one other RP family but not found in the 200 control chromosomes analyzed by Bascom et al. (1995) , or in a sample of 76 chromosomes studied here.
The mutant ROM1 allele could be directly involved in the disease as a dominant mutation with incomplete penetrance or highly variable expressivity. Some ADRP families showing highly heterogeneous phenotypic expression have been reported recently (Evans et al. 1995; Kim et al. 1995; Xu et al. 1995) . Alternatively, a digenic pattern involving ROM1 and another unidentified gene could be considered. Indeed, according to Bascom et al. (1992) a ROM1-peripherin/RDS complex of four subunits would associate with other proteins in rods. Alterations in any of these unknown proteins together with mutations in ROM1 could help explain this case of RP. However, in the absence of conclusive data, the pathogenicity of this mutant ROM1 allele is questionable. 
